Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T, Huber SC, de Moraes Martinelli B, Junior AL, Menezes FH, Orsi FA, Bittar LF, de Oliveira LFG, Sodre LR, Mello TT, Rielli G, Colella MP, de Paula EV, Yamaguti-Hayakawa GG, Montalvão S, Annichino-Bizzacchi JM.
Ferreira T, et al.
Vascul Pharmacol. 2020 Jan;124:106608. doi: 10.1016/j.vph.2019.106608. Epub 2019 Oct 31.
Vascul Pharmacol. 2020.
PMID: 31678199